Welcome to our dedicated page for TD SYNNEX CORPORATION SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for TD SYNNEX Corporation (NYSE: SNX), a global distributor and solutions aggregator for the IT ecosystem. Through these filings, investors can review the company’s official disclosures on financial performance, capital structure, governance and material events.
TD SYNNEX uses current reports on Form 8-K to announce items such as quarterly financial results, dividend declarations, executive leadership changes and financing activities. For example, recent 8-K filings describe fiscal quarter earnings releases furnished under Item 2.02, the declaration of cash dividends on common stock, and the issuance of senior notes due 2029 and 2035, including key terms and intended uses of proceeds.
Alongside 8-Ks, investors can consult annual reports on Form 10-K and quarterly reports on Form 10-Q (where available in the feed) for more detailed discussions of TD SYNNEX’s business, risk factors, segment information and financial statements. These core filings are complemented by other documents such as registration statements and prospectus supplements referenced in connection with debt offerings.
On Stock Titan, TD SYNNEX filings are updated in near real time from the SEC’s EDGAR system. AI-powered tools help summarize lengthy documents, highlight key sections and clarify non-GAAP metrics the company uses, such as non-GAAP gross billings, non-GAAP operating income, non-GAAP net income, non-GAAP diluted EPS, Adjusted EBITDA, free cash flow and adjusted return on invested capital. Users can also review disclosures related to executive appointments, compensation arrangements and other governance matters reported under Item 5.02 of Form 8-K.
Together, these filings offer a structured view of how TD SYNNEX reports its financial condition, capital markets activity and corporate developments to regulators and investors.
TD SYNNEX Corp director reports planned stock sales under Rule 10b5-1 plan. A board member of TD SYNNEX Corp (ticker SNX) filed details of two open-market sales of common stock dated 12/01/2025. The reporting person sold 2,438 shares at a weighted average price of $151.72 and 2,562 shares at a weighted average price of $152.48, both marked as disposition transactions.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025, which is designed to allow pre-arranged trading while addressing insider trading concerns. After these sales, the director beneficially owns 52,515 shares of TD SYNNEX common stock directly. The filing notes that the price figures represent weighted averages across multiple trades within stated price ranges and that full price breakdowns are available upon request.
TD SYNNEX (SNX) director and Hyve Solutions executive reported open‑market sales totaling 3,000 shares on 11/04/2025 under a Rule 10b5-1 trading plan adopted on October 13, 2024. The trust sold 600 shares at a weighted average price of $149.81 (range $149.50–$149.99), 1,761 shares at $150.59 (range $150.05–$150.99), and 639 shares at $151.21 (range $151.07–$151.36).
Following the transactions, beneficial ownership stood at 78,660 shares held indirectly by a trust and 34,099 shares held directly.
TD SYNNEX (SNX): FMR LLC filed an amended Schedule 13G reporting a passive beneficial ownership of 6,482,929.92 shares of TD SYNNEX common stock, representing 7.9% of the class as of 09/30/2025. FMR reports sole voting power over 6,454,541.96 shares and sole dispositive power over 6,482,929.92 shares, with no shared voting or dispositive power.
Abigail P. Johnson is also a reporting person, listing sole dispositive power over 6,482,929.92 shares and no voting power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. It notes that one or more other persons may have rights to receive dividends or sale proceeds, with no single such interest exceeding five percent of the total outstanding common stock.
TD SYNNEX (SNX) reported an insider transaction by a director. On 11/03/2025, the reporting person sold 336 shares of common stock at $155.79 per share, executed under a Rule 10b5-1 trading plan adopted on August 2, 2025. Following the sale, the insider beneficially owns 7,330 shares directly.
TD SYNNEX (SNX) reported an insider transaction: a director sold a total of 5,000 shares of common stock on 11/03/2025 pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025.
The sales were executed in multiple trades at weighted average prices of $152.57, $153.44, $154.27, and $155.20, with underlying trade ranges disclosed in the footnotes. Following these transactions, the reporting person directly owns 57,515 shares.
SNX filed a Form 144 notice for a proposed sale under Rule 144. The filing lists 504 common shares to be sold with an aggregate market value of 78,870.96, through Morgan Stanley Smith Barney LLC, on the NYSE with an approximate sale date of 11/03/2025. The shares were acquired as Restricted Stock Awards on 05/31/2025.
Shares outstanding were 81,437,855 at the time of the notice; this is a baseline figure, not the amount being offered.
TD SYNNEX (SNX) reported an insider transaction by a company officer (President, Europe). On 10/31/2025, the officer sold 1,573 shares at $156.49 and 100 shares at $156.52.
After these trades, the officer directly owned 16,529 shares of common stock, as reflected in the Form 4. The filing lists these as open-market sales and confirms direct ownership status.
Form 144 filed for a planned sale of common stock. A holder filed notice to sell up to 1,673 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value $261,810.61. The shares are slated for sale on or about 10/31/2025 on the NYSE.
The shares were acquired as restricted stock from the issuer in two grants: 25 shares on 04/01/2025 and 1,648 shares on 10/15/2025. Shares outstanding were 81,437,855 as of the notice, which provides scale for the planned sale.
SNX: A holder filed a Form 144 notice to sell up to 62,764 shares of common stock. The shares are listed on the NYSE, with an approximate sale date of 10/30/2025. The filing lists Morgan Stanley Smith Barney LLC as broker. The aggregate market value for the proposed sale is $9,789,401.50, and 81,437,855 shares were outstanding.
The seller acquired 62,764 shares on 10/30/2025 via a stock option exercise paid in cash. In the prior three months, the Witt Family Trust reported sales of 861 shares on 09/17/2025 for $129,012.24, 861 shares on 08/18/2025 for $126,997.50, and 862 shares on 08/11/2025 for $126,188.18.
JPMorgan Chase & Co. filed an amended Schedule 13G reporting beneficial ownership of 3,851,860 shares of TD SYNNEX (SNX) common stock, representing 4.7% of the class, as of 09/30/2025.
The filing lists sole voting power over 3,551,633 shares, shared voting power of 0, sole dispositive power over 3,847,779 shares, and shared dispositive power over 4,007 shares. It is filed as a parent holding company (HC), with subsidiaries including J.P. Morgan Securities LLC and JPMorgan Chase Bank, National Association. JPMorgan certified the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
FAQ
What is the current stock price of TD SYNNEX CORPORATION (SNX)?
What is the market cap of TD SYNNEX CORPORATION (SNX)?
